SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
128 hedge funds and large institutions have $62.9M invested in SANGAMO THERAPEUTICS INC in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 32 increasing their positions, 30 reducing their positions, and 16 closing their positions.
163% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 16
29% more capital invested
Capital invested by funds: $48.6M → $62.9M (+$14.3M)
24% more funds holding
Funds holding: 103 → 128 (+25)
2.52% more ownership
Funds ownership: 26.99% → 29.51% (+2.5%)
7% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 30
44% less call options, than puts
Call options by funds: $1.87M | Put options by funds: $3.35M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$7.96M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.15M |
| 3 |
IC
Ikarian Capital
Dallas,
Texas
|
+$3.4M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$3.13M |
| 5 |
BlackRock
New York
|
+$2.86M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$18.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$3.69M |
| 3 |
Renaissance Technologies
New York
|
-$3.23M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.33M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$748K |
SGMO Hedge Fund Activity: Q4 2024 in Review
128 of the 7,608 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q4 2024, worth a combined $62.9M — up 29% from $48.6M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new SGMO positions and 16 closed out — a net gain of 26 holders — while 32 added to existing stakes and 30 trimmed.
The largest buyer was State Street, adding an estimated $7.96M. The largest seller was Wasatch Advisors, cutting an estimated $18.7M.
- 128 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q4 2024, up from 103 in Q3 2024.
- Funds reported $62.9M of SANGAMO THERAPEUTICS INC stock for Q4 2024, up 29% quarter-over-quarter.
- 42 funds opened new SANGAMO THERAPEUTICS INC positions in Q4 2024 and 16 closed out, a net change of +26 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q4 2024 was State Street, an estimated $7.96M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q4 2024 was Wasatch Advisors, an estimated $18.7M sold.
Based on aggregated 13F filings for Q4 2024.